文献速递乳腺USMR

自动乳腺容积扫描仪(ABVS)与手持超声(HHUS)及对比增强磁共振成像(CE-MRI)在新辅助化疗早期评估乳腺癌中的比较:监测肿瘤反应的新作用?

Automated breast volume scanner (ABVS) compared to handheld ultrasound (HHUS) and contrast-enhanced magnetic resonance imaging (CE-MRI) in the early assessment of breast cancer during neoadjuvant chemotherapy: an emerging role to monitoring tumor response?
PubMed 文献 · Radiol Med · 2021-01-01

单机构前瞻性研究纳入21例接受新辅助化疗的浸润性乳腺癌患者,在诊断时和化疗3个月后行ABVS、HHUS和CE-MRI测量肿瘤大小变化,按中位数分为良好反应者和不良反应者,并与病理完全缓解(pCR)对照。ABVS和CE-MRI均将全部5例pCR归入良好反应组(p=0.01),HHUS未显示显著相关(p=0.31)。作者认为ABVS可能是有用工具,似乎比HHUS更可靠,与CE-MRI一样准确。

要点

  • ABVS和CE-MRI在早期识别新辅助化疗后可能达到pCR的患者中与病理结果显著相关(p=0.01)。
  • HHUS与pCR的相关性未达统计学显著(p=0.31)。
  • 作者认为ABVS似乎比HHUS更可靠,与CE-MRI一样准确。

核心结论

  • ABVS可能是有用工具,在早期识别新辅助化疗后可能达到pCR的患者方面似乎比HHUS更可靠,与CE-MRI一样准确。

研究设计与样本

  • 单机构前瞻性研究,纳入21例组织学诊断为浸润性乳腺癌、适合新辅助化疗并计划在本院手术的患者。
  • 在诊断时(基线)和化疗3个月后(中期)行ABVS、HHUS和CE-MRI检查,测量每个病灶的肿瘤大小并报告尺寸变化。
  • 根据中位数将患者二分为良好反应者(goodR)和不良反应者(poorR),结果与组织学评估(pCR versus No-pCR)用分类数据组间比较(Fisher精确检验)进行相关性分析。

诊断标准与关键数值

  • 共21例患者,5例获得pCR(23%)。
  • ABVS和CE-MRI均将全部5例pCR患者归入良好反应组(10例),而11例不良反应者中无1例获得pCR,相关性有统计学意义(p 0.01)。
  • HHUS中,良好反应组(10例)有1例获得pCR,不良反应组(11例)有4例获得pCR,相关性无统计学意义(p 0.31)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the role of automated breast volume scanner (ABVS) compared to handheld ultrasound (HHUS) and contrast-enhanced magnetic resonance imaging (CE-MRI) in the early detection of patients with locally advanced breast cancer who are more likely to reach a complete pathological response (pCR) during neoadjuvant chemotherapy (NAC).

METHODS: A single-institution prospective study was performed in patients with histological diagnosis of invasive breast cancer, eligible for NAC, and who were to undergo surgery in our Hospital. Imaging examinations with ABVS, HHUS and CE-MRI were performed at diagnosis (basal time) and after 3 months of chemotherapy (middle time). The tumor size of each lesion was measured at the basal and middle times, and the dimensional variation was reported. Based on this, patients were divided dichotomously by the median value, obtaining "good responders" (goodR) versus "poor responders" (poorR). The results were correlated with the histological assessment (pCR versus No-pCR) with the use of the intergroup comparison of categorical data (Fisher's exact test).

RESULT: A total of 21 patients were included; 5 obtained a pCR (23%). Both the ABVS and the CE-MRI found all 5 patients with pCR in the group of goodR (10 patients), while none of the poorR (11 patients) obtained a pCR [correlation was statistically significant (p 0.01)]. In the HHUS, goodR (10 patients) 1 obtained a pCR while in the poorR (11 patients) 4 obtained a pCR [correlation not statistically significant (p 0.31)].

CONCLUSIONS: ABVS could be a useful tool, appearing to be more reliable than HHUS, and as accurate as CE-MRI, in early detection of patients who could reach a pCR after NAC.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. D'Angelo A, Orlandi A, Bufi E, et al. Automated breast volume scanner (ABVS) compared to handheld ultrasound (HHUS) and contrast-enhanced magnetic resonance imaging (CE-MRI) in the early assessment of breast cancer during neoadjuvant chemotherapy: an emerging role to monitoring tumor response? Radiol Med. 2021. PMID: 33385300. doi:10.1007/s11547-020-01319-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。